FDA Panel Unanimously Recommends Centocor’s Ustekinumab

But Dermatologic and Ophthalmic Drugs panel says the proposal for long-term safety follow-up is inadequate.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet